Manager × security

Parametrica Management Ltd IOVA holdings history

Who else holds this security? →

IOVANCE BIOTHERAPEUTICS INC · CUSIP 462260100 · CIK 1535110

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Parametrica Management Ltd reported 195.88K IOVA (shares), valued at $814.85K, or 0.64% of its reported non-derivative portfolio. Filed 2026-08-12.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
0.64%
Shares
195.88K
195,878
Reported value
$814.85K
USD

Shares unchanged; reported value increased 18.52%, and weight changed -0.14 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20260.64%195,878SEC filing ↗Filed Aug 12, 2026
Q1 20260.78%195,878SEC filing ↗Filed May 11, 2026
Q4 20250.82%195,878SEC filing ↗Filed Feb 10, 2026
Q3 20250.66%195,878SEC filing ↗Filed Nov 12, 2025
Q2 20250.63%195,878SEC filing ↗Filed Aug 11, 2025
Q1 20251.10%195,878SEC filing ↗Filed May 8, 2025
Q4 20242.55%261,090SEC filing ↗Filed Feb 12, 2025
Q3 20242.92%261,090SEC filing ↗Filed Nov 5, 2024
Q2 20242.77%261,090SEC filing ↗Filed Aug 8, 2024
Q1 20242.81%131,590SEC filing ↗Filed May 10, 2024
Q4 20234.27%320,276SEC filing ↗Filed Feb 2, 2024
Q3 20230.73%95,400SEC filing ↗Filed Oct 31, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20230.73%95,400$434.07KThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Oct 31, 2023
Q4 20234.27%320,276$2.60MShares increased 235.72%; reported value increased 499.87%, and weight changed +3.54 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 2, 2024
Q1 20242.81%131,590$1.95MShares decreased 58.91%; reported value decreased 25.10%, and weight changed -1.46 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 10, 2024
Q2 20242.77%261,090$2.09MShares increased 98.41%; reported value increased 7.37%, and weight changed -0.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 8, 2024
Q3 20242.92%261,090$2.45MShares unchanged; reported value increased 17.08%, and weight changed +0.15 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 5, 2024
Q4 20242.55%261,090$1.93MShares unchanged; reported value decreased 21.19%, and weight changed -0.37 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 12, 2025
Q1 20251.10%195,878$652.27KShares decreased 24.98%; reported value decreased 66.24%, and weight changed -1.45 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 8, 2025
Q2 20250.63%195,878$336.91KShares unchanged; reported value decreased 48.35%, and weight changed -0.47 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 11, 2025
Q3 20250.66%195,878$425.06KShares unchanged; reported value increased 26.16%, and weight changed +0.03 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 12, 2025
Q4 20250.82%195,878$534.75KShares unchanged; reported value increased 25.81%, and weight changed +0.16 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 10, 2026
Q1 20260.78%195,878$687.53KShares unchanged; reported value increased 28.57%, and weight changed -0.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 11, 2026
Q2 20260.64%195,878$814.85KShares unchanged; reported value increased 18.52%, and weight changed -0.14 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 12, 2026
Parametrica Management Ltd · IOVANCE BIOTHERAPEUTICS INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1535110","quarter":"2026Q2","cusip":"462260100"}

get_institutional_manager_history
{"cik":"1535110","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.